Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1775, Issue 2, 2007, Pages 298-312

  Dejana, Elisabetta ^a,b,c   Taddei, Andrea ^a   Randi, Anna M ^d  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Angiogenesis; Cell transcription; Ets transcription factors; Forkhead transcription factors; Vasculogenesis

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR FOX; TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR FOXC2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTERY ENDOTHELIUM; CELL DIFFERENTIATION; CONSENSUS; DNA SEQUENCE; ENDOTHELIUM CELL; HUMAN; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION, GENETIC;

MUS;

EID: 34250214921     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2007.05.003     Document Type: Review

References (169)

1. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 7070 (2005) 932-936
2. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 7070 (2005) 967-974
3. Ruegg C., et al. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochim. Biophys. Acta 1765 2 (2006) 155-177
4. Fukumura D., and Jain R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell. Biochem. (2006) 10.1002/jcb.21187
5. McDonald D.M., and Baluk P. Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture. Chest 128 6 Suppl. (2005) 602S-608S
6. Adams R.H. Molecular control of arterial-venous blood vessel identity. J. Anat. 202 1 (2003) 105-112
7. Gorski D.H., and Walsh K. Control of vascular cell differentiation by homeobox transcription factors. Circ. Res. 88 1 (2001) 7-8
8. Iso T., Hamamori Y., and Kedes L. Notch signaling in vascular development. Arterioscler. Thromb. Vasc. Biol. 23 4 (2003) 543-553
9. Lamont R.E., and Childs S. MAPping out arteries and veins. Sci. STKE 2006 355 (2006) pe39
10. Lelievre E., et al. The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int. J. Biochem. Cell Biol. 33 4 (2001) 391-407
11. Minami T., and Aird W.C. Endothelial cell gene regulation. Trends Cardiovasc. Med. 15 5 (2005) 174-184
12. Oettgen P. Transcriptional regulation of vascular development. Circ. Res. 89 5 (2001) 380-388
13. Sato Y., et al. Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis. Ann. N. Y. Acad. Sci. 947 (2001) 117-123
14. Torres-Vazquez J., Kamei M., and Weinstein B.M. Molecular distinction between arteries and veins. Cell Tissue Res. 314 1 (2003) 43-59
15. Risau W. Mechanisms of angiogenesis. Nature 386 6626 (1997) 671-674
16. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 6801 (2000) 249-257
17. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 277 5322 (1997) 48-50
18. Iljin K., et al. Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter. FASEB J. 13 2 (1999) 377-386
19. Minami T., et al. Ets motifs are necessary for endothelial cell-specific expression of a 723-bp Tie-2 promoter/enhancer in Hprt targeted transgenic mice. Arterioscler. Thromb. Vasc. Biol. 23 11 (2003) 2041-2047
20. Gory S., et al. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J. Biol. Chem. 273 12 (1998) 6750-6755
21. Kappel A., et al. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood 96 9 (2000) 3078-3085
22. Deleuze V., et al. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol. Cell. Biol. 27 7 (2007) 2687-2697
23. Furuyama T., et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279 33 (2004) 34741-34749
24. Hosaka T., et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101 9 (2004) 2975-2980
25. Paik J.H., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128 2 (2007) 309-323
26. Potente M., et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115 9 (2005) 2382-2392
27. Seo S., et al. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev. Biol. 294 2 (2006) 458-470
28. Petrova T.V., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10 9 (2004) 974-981
29. Barton K., et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9 4 (1998) 555-563
30. Spyropoulos D.D., et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol. Cell. Biol. 20 15 (2000) 5643-5652
31. Hart A., et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13 2 (2000) 167-177
32. Wang L.C., et al. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16 14 (1997) 4374-4383
33. Gorski D.H., and Walsh K. The role of homeobox genes in vascular remodeling and angiogenesis. Circ. Res. 87 10 (2000) 865-872
34. Irrthum A., et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 72 6 (2003) 1470-1478
35. Pennisi D., et al. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat. Genet. 24 4 (2000) 434-437
36. Kuhnert F., et al. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev. Biol. 283 1 (2005) 140-156
37. Perk J., Iavarone A., and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat. Rev., Cancer 5 8 (2005) 603-614
38. Fraidenraich D., et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science 306 5694 (2004) 247-252
39. Fischer A., et al. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18 8 (2004) 901-911
40. You L.R., et al. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435 7038 (2005) 98-104
41. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 6 (1999) 769-778
42. Rossig L., et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J. Exp. Med. 201 11 (2005) 1825-1835
43. Bruhl T., et al. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ. Res. 94 6 (2004) 743-751
44. Myers C., Charboneau A., and Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148 2 (2000) 343-351
45. Downes M., and Koopman P. SOX18 and the transcriptional regulation of blood vessel development. Trends Cardiovasc. Med. 11 8 (2001) 318-324
46. Adams R.H., et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13 3 (1999) 295-306
47. Lawson N.D., Vogel A.M., and Weinstein B.M. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3 1 (2002) 127-136
48. Wang H.U., Chen Z.F., and Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93 5 (1998) 741-753
49. Zhong T.P., et al. Gridlock signalling pathway fashions the first embryonic artery. Nature 414 6860 (2001) 216-220
50. Petrova T.V., et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21 17 (2002) 4593-4599
51. Weigel D., and Jackle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?. Cell 63 3 (1990) 455-456
52. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 4 (2004) 421-426
53. Birkenkamp K.U., and Coffer P.J. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31 Pt 1 (2003) 292-297
54. Paik J.H. FOXOs in the maintenance of vascular homoeostasis. Biochem. Soc. Trans. 34 Pt 5 (2006) 731-734
55. Alvarez B., et al. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 413 6857 (2001) 744-747
56. Brunet A., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 6 (1999) 857-868
57. Siegel R.M., et al. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1 6 (2000) 469-474
58. Tang T.T., et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem. 277 16 (2002) 14255-14265
59. Dijkers P.F., et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10 19 (2000) 1201-1204
60. Stahl M., et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168 10 (2002) 5024-5031
61. Daly C., et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18 9 (2004) 1060-1071
62. Urbich C., et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J. 19 8 (2005) 974-976
63. Skurk C., et al. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem. 279 2 (2004) 1513-1525
64. Sessa W.C. eNOS at a glance. J. Cell Sci. 117 Pt 12 (2004) 2427-2429
65. Kops G.J., et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol. 22 7 (2002) 2025-2036
66. Medema R.H., et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404 6779 (2000) 782-787
67. Schmidt M., et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 22 22 (2002) 7842-7852
68. Furukawa-Hibi Y., et al. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J. Biol. Chem. 277 30 (2002) 26729-26732
69. Tran H., et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296 5567 (2002) 530-534
70. Ayadi A., et al. Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech. Dev. 102 1-2 (2001) 205-208
71. Zheng H., et al. The transcription factor Net regulates the angiogenic switch. Genes Dev. 17 18 (2003) 2283-2297
72. Clark K.L., et al. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364 6436 (1993) 412-420
73. Jin C., et al. Dynamic DNA contacts observed in the NMR structure of winged helix protein-DNA complex. J. Mol. Biol. 289 4 (1999) 683-690
74. Seoane J., et al. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 2 (2004) 211-223
75. Biggs III W.H., et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U. S. A. 96 13 (1999) 7421-7426
76. Brunet A., et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156 5 (2002) 817-828
77. Burgering B.M., and Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27 7 (2002) 352-360
78. Zhang X., et al. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J. Biol. Chem. 277 47 (2002) 45276-45284
79. Brownawell A.M., et al. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21 10 (2001) 3534-3546
80. Yaffe M.B., et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91 7 (1997) 961-971
81. Abid M.R., et al. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24 2 (2004) 294-300
82. Abid M.R., et al. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J. Biol. Chem. 281 46 (2006) 35544-35553
83. Fosbrink M., et al. C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J. Biol. Chem. 281 28 (2006) 19009-19018
84. Potente M., et al. 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J. Biol. Chem. 278 32 (2003) 29619-29625
85. Chlench S., et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett. 581 4 (2007) 673-680
86. Nakamura N., et al. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20 23 (2000) 8969-8982
87. Huang J., and Kontos C.D. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J. Biol. Chem. 277 13 (2002) 10760-10766
88. Wen S., et al. PTEN controls tumor-induced angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 98 8 (2001) 4622-4627
89. Asada S., et al. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell. Signal. 19 3 (2006) 519-527
90. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 5666 (2004) 2011-2015
91. Motta M.C., et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 4 (2004) 551-563
92. van der Horst A., et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 8 10 (2006) 1064-1073
93. Chen J., et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11 11 (2005) 1188-1196
94. van Dongen M.J., et al. Solution structure and dynamics of the DNA-binding domain of the adipocyte-transcription factor FREAC-11. J. Mol. Biol. 296 2 (2000) 351-359
95. Leprince D., et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306 5941 (1983) 395-397
96. Nunn M.F., et al. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306 5941 (1983) 391-395
97. Maroulakou I.G., and Bowe D.B. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene 19 55 (2000) 6432-6442
98. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev., Mol. Cell Biol. 2 11 (2001) 827-837
99. Laudet V., et al. Molecular phylogeny of the ETS gene family. Oncogene 18 6 (1999) 1351-1359
100. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct. Funct. 26 1 (2001) 19-24
101. Karim F.D., et al. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 4 9 (1990) 1451-1453
102. Sementchenko V.I., and Watson D.K. Ets target genes: past, present and future. Oncogene 19 55 (2000) 6533-6548
103. Hsu T., Trojanowska M., and Watson D.K. Ets proteins in biological control and cancer. J. Cell. Biochem. 91 5 (2004) 896-903
104. Petrovics G., et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24 23 (2005) 3847-3852
105. Delattre O., et al. The Ewing family of tumors-A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med. 331 5 (1994) 294-299
106. Mavrothalassitis G., and Ghysdael J. Proteins of the ETS family with transcriptional repressor activity. Oncogene 19 55 (2000) 6524-6532
107. Buttice G., et al. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13 11 (1996) 2297-2306
108. Oikawa T., and Yamada T. Molecular biology of the Ets family of transcription factors. Gene 303 (2003) 11-34
109. Wang C.Y., et al. Evolutionarily conserved Ets family members display distinct DNA binding specificities. J. Exp. Med. 175 5 (1992) 1391-1399
110. Yang B.S., et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16 2 (1996) 538-547
111. Yang S.H., et al. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17 6 (1998) 1740-1749
112. Cowley D.O., and Graves B.J. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev. 14 3 (2000) 366-376
113. Maki K., et al. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol. Cell. Biol. 24 8 (2004) 3227-3237
114. Angel P., et al. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7 6 (1987) 2256-2266
115. Gutman A., and Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9 7 (1990) 2241-2246
116. Carrere S., et al. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene 16 25 (1998) 3261-3268
117. Wang L., and Hiebert S.W. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20 28 (2001) 3716-3725
118. Yang L., et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. Biochem. J. 369 Pt 3 (2003) 651-657
119. Matsui Y., et al. COL11A2 collagen gene transcription is differentially regulated by EWS/ERG sarcoma fusion protein and wild-type ERG. J. Biol. Chem. 278 13 (2003) 11369-11375
120. Papoutsopoulou S., and Janknecht R. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol. Cell. Biol. 20 19 (2000) 7300-7310
121. Wang H., et al. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J. Biol. Chem. 279 24 (2004) 25241-25250
122. Yang C., et al. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell. Biol. 18 4 (1998) 2218-2229
123. Tootle T.L., and Rebay I. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. BioEssays 27 3 (2005) 285-298
124. Verger A., and Duterque-Coquillaud M. When Ets transcription factors meet their partners. BioEssays 24 4 (2002) 362-370
125. Li R., Pei H., and Watson D.K. Regulation of Ets function by protein-protein interactions. Oncogene 19 55 (2000) 6514-6523
126. Li R., et al. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19 6 (2000) 745-753
127. Patterson L.J., and Patient R. The "Ets" factor: vessel formation in zebrafish - the missing link?. PLoS Biol. 4 1 (2006) e24
128. Pham V.N., et al. Combinatorial function of ETS transcription factors in the developing vasculature. Dev. Biol. 303 2 (2007) 772-783
129. Dube A., et al. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. Circ. Res. 84 10 (1999) 1177-1185
130. Wakiya K., et al. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J. Biol. Chem. 271 48 (1996) 30823-30828
131. Teruyama K., et al. Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells. FEBS Lett. 504 1-2 (2001) 1-4
132. Schwachtgen J.L., et al. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene 15 25 (1997) 3091-3102
133. McLaughlin F., et al. Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. Blood 98 12 (2001) 3332-3339
134. Wasylyk C., et al. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10 5 (1991) 1127-1134
135. Oda N., Abe M., and Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J. Cell. Physiol. 178 2 (1999) 121-132
136. Logan S.K., et al. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271 2 (1996) 774-782
137. Nerlov C., et al. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6 9 (1991) 1583-1592
138. Pimanda J.E., et al. Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer. Blood 107 12 (2006) 4737-4745
139. Karantzoulis-Fegaras F., et al. Characterization of the human endothelial nitric-oxide synthase promoter. J. Biol. Chem. 274 5 (1999) 3076-3093
140. Deramaudt B.M., Remy P., and Abraham N.G. Upregulation of human heme oxygenase gene expression by Ets-family proteins. J. Cell. Biochem. 72 3 (1999) 311-321
141. Lelievre E., et al. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin. Oncogene 19 20 (2000) 2438-2446
142. Hollenhorst P.C., Jones D.A., and Graves B.J. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32 18 (2004) 5693-5702
143. Chotteau-Lelievre A., et al. Differential expression patterns of the PEA3 group transcription factors through murine embryonic development. Oncogene 15 8 (1997) 937-952
144. Huang X., et al. Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood 107 8 (2006) 3153-3160
145. Bories J.C., et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377 6550 (1995) 635-638
146. Muthusamy N., Barton K., and Leiden J.M. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377 6550 (1995) 639-642
147. Iwasaka C., et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol. 169 3 (1996) 522-531
148. Tanaka K., et al. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J. Cell. Physiol. 176 2 (1998) 235-244
149. McLaughlin F., et al. Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter. J. Cell Sci. 112 Pt 24 (1999) 4695-4703
150. Dittmer J. The biology of the Ets1 proto-oncogene. Mol. Cancer 2 (2003) 29
151. Oikawa M., et al. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 289 1 (2001) 39-43
152. Tajima A., et al. Mouse integrin alphav promoter is regulated by transcriptional factors Ets and Sp1 in melanoma cells. Biochim. Biophys. Acta 1492 2-3 (2000) 377-384
153. Nakano T., et al. Angiogenesis inhibition by transdominant mutant Ets-1. J. Cell. Physiol. 184 2 (2000) 255-262
154. Watanabe D., et al. Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization. Am. J. Pathol. 164 5 (2004) 1827-1835
155. Hashiya N., et al. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109 24 (2004) 3035-3041
156. Owczarek C.M., et al. Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene 324 (2004) 65-77
157. Baltzinger M., Mager-Heckel A.M., and Remy P. Xl erg: expression pattern and overexpression during development plead for a role in endothelial cell differentiation. Dev. Dyn. 216 4-5 (1999) 420-433
158. Vlaeminck-Guillem V., et al. The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis. Mech. Dev. 91 1-2 (2000) 331-335
159. Watson D.K., et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 3 10 (1992) 705-713
160. Ben-David Y., Giddens E.B., and Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 87 4 (1990) 1332-1336
161. Lelievre E., et al. Ets-1 regulates fli-1 expression in endothelial cells. Identification of ETS binding sites in the fli-1 gene promoter. J. Biol. Chem. 277 28 (2002) 25143-25151
162. Brown L.A., et al. Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech. Dev. 90 2 (2000) 237-252
163. Lawson N.D., and Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248 2 (2002) 307-318
164. Folpe A.L., et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am. J. Surg. Pathol. 25 8 (2001) 1061-1066
165. Dalgleish P., and Sharrocks A.D. The mechanism of complex formation between Fli-1 and SRF transcription factors. Nucleic Acids Res. 28 2 (2000) 560-569
166. Bassuk A.G., and Leiden J.M. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3 2 (1995) 223-237
167. Kwiatkowski B.A., et al. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273 28 (1998) 17525-17530
168. Edel M.J. The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-cells. Anticancer Res. 18 6A (1998) 4505-4509
169. Lopez R.G., et al. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274 42 (1999) 30132-30138